Literature DB >> 8438466

Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.

A S Chong1, H Gebel, A Finnegan, E E Petraitis, X L Jiang, H N Sankary, P Foster, J W Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8438466

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; A Jain
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

2.  Leflunomide interferes with pyrimidine nucleotide biosynthesis.

Authors:  H M Cherwinski; N Byars; S J Ballaron; G M Nakano; J M Young; J T Ransom
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

3.  A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

Authors:  R Shapiro; M Jordan; V Scantlebury; C Vivas; J Fung; J McCauley; A Tzakis; P Randhawa; A J Demetris; W Irish
Journal:  Clin Transplant       Date:  1994-12       Impact factor: 2.863

4.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

5.  FK506 in pediatric kidney transplantation--primary and rescue experience.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; A G Tzakis; D Ellis; N Gilboa; L Hopp; J McCauley; W Irish
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

6.  Leflunomide therapy following penetrating keratoplasty in the rat.

Authors:  S E Coupland; S Klebe; A C Karow; L Krause; H Kruse; R R Bartlett; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

7.  Saliva as Blood Alternative in Therapeutic Monitoring of Teriflunomide-Development and Validation of the Novel Analytical Method.

Authors:  Bartłomiej Sankowski; Sylwia Michorowska; Emilia Raćkowska; Mariusz Sikora; Joanna Giebułtowicz
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.